Table of Content

1 Report Overview
1.1 Liposomes Definition
1.2 Market by Type
1.2.1 Global Liposomes Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Liposomes Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Liposomes Sales
2.1 Global Liposomes Revenue Estimates and Forecasts 2018-2034
2.2 Global Liposomes Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Liposomes Revenue by Region
2.3.1 Global Liposomes Revenue by Region (2018-2023)
2.3.2 Global Liposomes Revenue by Region (2024-2034)
2.4 Global Liposomes Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Liposomes Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Liposomes Sales Quantity by Region
2.6.1 Global Liposomes Sales Quantity by Region (2018-2023)
2.6.2 Global Liposomes Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Liposomes Sales Quantity by Manufacturers
3.1.1 Global Liposomes Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Liposomes Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Liposomes Sales in 2024
3.2 Global Liposomes Revenue by Manufacturers
3.2.1 Global Liposomes Revenue by Manufacturers (2018-2023)
3.2.2 Global Liposomes Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Liposomes Revenue in 2024
3.3 Global Liposomes Sales Price by Manufacturers
3.4 Global Key Players of Liposomes, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Liposomes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Liposomes, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Liposomes, Product Offered and Application
3.8 Global Key Manufacturers of Liposomes, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Liposomes Sales Quantity by Type
4.1.1 Global Liposomes Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Liposomes Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Liposomes Sales Quantity Market Share by Type (2018-2034)
4.2 Global Liposomes Revenue by Type
4.2.1 Global Liposomes Historical Revenue by Type (2018-2023)
4.2.2 Global Liposomes Forecasted Revenue by Type (2024-2034)
4.2.3 Global Liposomes Revenue Market Share by Type (2018-2034)
4.3 Global Liposomes Price by Type
4.3.1 Global Liposomes Price by Type (2018-2023)
4.3.2 Global Liposomes Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Liposomes Sales Quantity by Application
5.1.1 Global Liposomes Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Liposomes Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Liposomes Sales Quantity Market Share by Application (2018-2034)
5.2 Global Liposomes Revenue by Application
5.2.1 Global Liposomes Historical Revenue by Application (2018-2023)
5.2.2 Global Liposomes Forecasted Revenue by Application (2024-2034)
5.2.3 Global Liposomes Revenue Market Share by Application (2018-2034)
5.3 Global Liposomes Price by Application
5.3.1 Global Liposomes Price by Application (2018-2023)
5.3.2 Global Liposomes Price Forecast by Application (2024-2034)
6 North America
6.1 North America Liposomes Sales by Company
6.1.1 North America Liposomes Revenue by Company (2018-2023)
6.1.2 North America Liposomes Sales Quantity by Company (2018-2023)
6.2 North America Liposomes Market Size by Type
6.2.1 North America Liposomes Sales Quantity by Type (2018-2034)
6.2.2 North America Liposomes Revenue by Type (2018-2034)
6.3 North America Liposomes Market Size by Application
6.3.1 North America Liposomes Sales Quantity by Application (2018-2034)
6.3.2 North America Liposomes Revenue by Application (2018-2034)
6.4 North America Liposomes Market Size by Country
6.4.1 North America Liposomes Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Liposomes Revenue by Country (2018-2034)
6.4.3 North America Liposomes Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Liposomes Sales by Company
7.1.1 Europe Liposomes Sales Quantity by Company (2018-2023)
7.1.2 Europe Liposomes Revenue by Company (2018-2023)
7.2 Europe Liposomes Market Size by Type
7.2.1 Europe Liposomes Sales Quantity by Type (2018-2034)
7.2.2 Europe Liposomes Revenue by Type (2018-2034)
7.3 Europe Liposomes Market Size by Application
7.3.1 Europe Liposomes Sales Quantity by Application (2018-2034)
7.3.2 Europe Liposomes Revenue by Application (2018-2034)
7.4 Europe Liposomes Market Size by Country
7.4.1 Europe Liposomes Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Liposomes Revenue by Country (2018-2034)
7.4.3 Europe Liposomes Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Liposomes Sales by Company
8.1.1 China Liposomes Sales Quantity by Company (2018-2023)
8.1.2 China Liposomes Revenue by Company (2018-2023)
8.2 China Liposomes Market Size by Type
8.2.1 China Liposomes Sales Quantity by Type (2018-2034)
8.2.2 China Liposomes Revenue by Type (2018-2034)
8.3 China Liposomes Market Size by Application
8.3.1 China Liposomes Sales Quantity by Application (2018-2034)
8.3.2 China Liposomes Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Liposomes Sales by Company
9.1.1 APAC Liposomes Sales Quantity by Company (2018-2023)
9.1.2 APAC Liposomes Revenue by Company (2018-2023)
9.2 APAC Liposomes Market Size by Type
9.2.1 APAC Liposomes Sales Quantity by Type (2018-2034)
9.2.2 APAC Liposomes Revenue by Type (2018-2034)
9.3 APAC Liposomes Market Size by Application
9.3.1 APAC Liposomes Sales Quantity by Application (2018-2034)
9.3.2 APAC Liposomes Revenue by Application (2018-2034)
9.4 APAC Liposomes Market Size by Region
9.4.1 APAC Liposomes Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Liposomes Revenue by Region (2018-2034)
9.4.3 APAC Liposomes Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Liposomes Sales by Company
10.1.1 Middle East, Africa and Latin America Liposomes Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Liposomes Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Liposomes Market Size by Type
10.2.1 Middle East, Africa and Latin America Liposomes Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Liposomes Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Liposomes Market Size by Application
10.3.1 Middle East, Africa and Latin America Liposomes Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Liposomes Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Liposomes Market Size by Country
10.4.1 Middle East, Africa and Latin America Liposomes Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Liposomes Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Liposomes Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Johnson & Johnson Liposomes Products and Services
11.1.5 Johnson & Johnson Liposomes SWOT Analysis
11.1.6 Johnson & Johnson Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Overview
11.2.3 Gilead Sciences Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Gilead Sciences Liposomes Products and Services
11.2.5 Gilead Sciences Liposomes SWOT Analysis
11.2.6 Gilead Sciences Recent Developments
11.3 Pacira
11.3.1 Pacira Company Information
11.3.2 Pacira Overview
11.3.3 Pacira Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Pacira Liposomes Products and Services
11.3.5 Pacira Liposomes SWOT Analysis
11.3.6 Pacira Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Overview
11.4.3 Sun Pharmaceutical Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Sun Pharmaceutical Liposomes Products and Services
11.4.5 Sun Pharmaceutical Liposomes SWOT Analysis
11.4.6 Sun Pharmaceutical Recent Developments
11.5 Luye Pharma
11.5.1 Luye Pharma Company Information
11.5.2 Luye Pharma Overview
11.5.3 Luye Pharma Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Luye Pharma Liposomes Products and Services
11.5.5 Luye Pharma Liposomes SWOT Analysis
11.5.6 Luye Pharma Recent Developments
11.6 Sigma-Tau Group
11.6.1 Sigma-Tau Group Company Information
11.6.2 Sigma-Tau Group Overview
11.6.3 Sigma-Tau Group Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Sigma-Tau Group Liposomes Products and Services
11.6.5 Sigma-Tau Group Liposomes SWOT Analysis
11.6.6 Sigma-Tau Group Recent Developments
11.7 Fudan-Zhangjiang
11.7.1 Fudan-Zhangjiang Company Information
11.7.2 Fudan-Zhangjiang Overview
11.7.3 Fudan-Zhangjiang Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Fudan-Zhangjiang Liposomes Products and Services
11.7.5 Fudan-Zhangjiang Liposomes SWOT Analysis
11.7.6 Fudan-Zhangjiang Recent Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Information
11.8.2 Teva Pharmaceutical Overview
11.8.3 Teva Pharmaceutical Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Teva Pharmaceutical Liposomes Products and Services
11.8.5 Teva Pharmaceutical Liposomes SWOT Analysis
11.8.6 Teva Pharmaceutical Recent Developments
11.9 CSPC
11.9.1 CSPC Company Information
11.9.2 CSPC Overview
11.9.3 CSPC Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 CSPC Liposomes Products and Services
11.9.5 CSPC Liposomes SWOT Analysis
11.9.6 CSPC Recent Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Overview
11.10.3 Novartis Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Novartis Liposomes Products and Services
11.10.5 Novartis Liposomes SWOT Analysis
11.10.6 Novartis Recent Developments
11.11 Kingond Pharm
11.11.1 Kingond Pharm Company Information
11.11.2 Kingond Pharm Overview
11.11.3 Kingond Pharm Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Kingond Pharm Liposomes Products and Services
11.11.5 Kingond Pharm Recent Developments
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Information
11.12.2 Spectrum Pharmaceuticals Overview
11.12.3 Spectrum Pharmaceuticals Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Spectrum Pharmaceuticals Liposomes Products and Services
11.12.5 Spectrum Pharmaceuticals Recent Developments
11.13 Shanghai New Asia
11.13.1 Shanghai New Asia Company Information
11.13.2 Shanghai New Asia Overview
11.13.3 Shanghai New Asia Liposomes Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Shanghai New Asia Liposomes Products and Services
11.13.5 Shanghai New Asia Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Liposomes Value Chain Analysis
12.2 Liposomes Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Liposomes Production Mode & Process
12.4 Liposomes Sales and Marketing
12.4.1 Liposomes Sales Channels
12.4.2 Liposomes Distributors
12.5 Liposomes Customers
13 Market Dynamics
13.1 Liposomes Industry Trends
13.2 Liposomes Market Drivers
13.3 Liposomes Market Challenges
13.4 Liposomes Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Liposomes Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Liposomal Doxorubicin
Table 3. Major Manufacturers of Liposomal Amphoteracin B
Table 4. Major Manufacturers of Liposomal Paclitaxel
Table 5. Major Manufacturers of Others
Table 6. Global Liposomes Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Liposomes Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Liposomes Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Liposomes Revenue Market Share by Region (2018-2023)
Table 10. Global Liposomes Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Liposomes Revenue Market Share by Region (2024-2034)
Table 12. Global Liposomes Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 13. Global Liposomes Sales by Region (2018-2023) & (K Units)
Table 14. Global Liposomes Sales Market Share by Region (2018-2023)
Table 15. Global Liposomes Sales by Region (2024-2034) & (K Units)
Table 16. Global Liposomes Sales Market Share by Region (2024-2034)
Table 17. Global Liposomes Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 18. Global Liposomes Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global Liposomes Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Liposomes Revenue Share by Manufacturers (2018-2023)
Table 21. Global Liposomes Price by Manufacturers 2018-2023 (USD/Unit)
Table 22. Global Key Players of Liposomes, Industry Ranking, 2021 VS 2024
Table 23. Global Liposomes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Liposomes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomes as of 2024)
Table 25. Global Key Manufacturers of Liposomes, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Liposomes, Product Offered and Application
Table 27. Global Key Manufacturers of Liposomes, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Liposomes Sales Quantity by Type (2018-2023) & (K Units)
Table 30. Global Liposomes Sales Quantity by Type (2024-2034) & (K Units)
Table 31. Global Liposomes Sales Quantity Share by Type (2018-2023)
Table 32. Global Liposomes Sales Quantity Share by Type (2024-2034)
Table 33. Global Liposomes Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Liposomes Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Liposomes Revenue Share by Type (2018-2023)
Table 36. Global Liposomes Revenue Share by Type (2024-2034)
Table 37. Liposomes Price by Type (2018-2023) & (USD/Unit)
Table 38. Global Liposomes Price Forecast by Type (2024-2034) & (USD/Unit)
Table 39. Global Liposomes Sales Quantity by Application (2018-2023) & (K Units)
Table 40. Global Liposomes Sales Quantity by Application (2024-2034) & (K Units)
Table 41. Global Liposomes Sales Quantity Share by Application (2018-2023)
Table 42. Global Liposomes Sales Quantity Share by Application (2024-2034)
Table 43. Global Liposomes Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Liposomes Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Liposomes Revenue Share by Application (2018-2023)
Table 46. Global Liposomes Revenue Share by Application (2024-2034)
Table 47. Liposomes Price by Application (2018-2023) & (USD/Unit)
Table 48. Global Liposomes Price Forecast by Application (2024-2034) & (USD/Unit)
Table 49. North America Liposomes Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America Liposomes Sales Quantity by Company (2018-2023) & (K Units)
Table 51. North America Liposomes Sales Quantity by Type (2018-2023) & (K Units)
Table 52. North America Liposomes Sales Quantity by Type (2024-2034) & (K Units)
Table 53. North America Liposomes Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America Liposomes Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Liposomes Sales Quantity by Application (2018-2023) & (K Units)
Table 56. North America Liposomes Sales Quantity by Application (2024-2034) & (K Units)
Table 57. North America Liposomes Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America Liposomes Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Liposomes Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America Liposomes Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America Liposomes Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Liposomes Sales Quantity by Country (2018-2023) & (K Units)
Table 63. North America Liposomes Sales Quantity by Country (2024-2034) & (K Units)
Table 64. Europe Liposomes Sales Quantity by Company (2018-2023) & (K Units)
Table 65. Europe Liposomes Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe Liposomes Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Europe Liposomes Sales Quantity by Type (2024-2034) & (K Units)
Table 68. Europe Liposomes Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Liposomes Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Liposomes Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Liposomes Sales Quantity by Application (2024-2034) & (K Units)
Table 72. Europe Liposomes Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Liposomes Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Liposomes Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe Liposomes Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Liposomes Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Liposomes Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Liposomes Sales Quantity by Country (2024-2034) & (K Units)
Table 79. China Liposomes Sales Quantity by Company (2018-2023) & (K Units)
Table 80. China Liposomes Revenue by Company (2018-2023) & (US$ Million)
Table 81. China Liposomes Sales Quantity by Type (2018-2023) & (K Units)
Table 82. China Liposomes Sales Quantity by Type (2024-2034) & (K Units)
Table 83. China Liposomes Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Liposomes Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Liposomes Sales Quantity by Application (2018-2023) & (K Units)
Table 86. China Liposomes Sales Quantity by Application (2024-2034) & (K Units)
Table 87. China Liposomes Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Liposomes Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Liposomes Sales Quantity by Company (2018-2023) & (K Units)
Table 90. APAC Liposomes Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC Liposomes Sales Quantity by Type (2018-2023) & (K Units)
Table 92. APAC Liposomes Sales Quantity by Type (2024-2034) & (K Units)
Table 93. APAC Liposomes Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC Liposomes Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Liposomes Sales Quantity by Application (2018-2023) & (K Units)
Table 96. APAC Liposomes Sales Quantity by Application (2024-2034) & (K Units)
Table 97. APAC Liposomes Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC Liposomes Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Liposomes Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC Liposomes Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC Liposomes Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Liposomes Sales Quantity by Region (2018-2023) & (K Units)
Table 103. APAC Liposomes Sales Quantity by Region (2024-2034) & (K Units)
Table 104. Middle East, Africa and Latin America Liposomes Sales Quantity by Company (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Liposomes Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Liposomes Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Liposomes Sales Quantity by Type (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America Liposomes Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Liposomes Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Liposomes Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Middle East, Africa and Latin America Liposomes Sales Quantity by Application (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America Liposomes Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America Liposomes Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Liposomes Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Liposomes Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Liposomes Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Liposomes Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Middle East, Africa and Latin America Liposomes Sales Quantity by Country (2024-2034) & (K Units)
Table 119. Johnson & Johnson Company Information
Table 120. Johnson & Johnson Description and Overview
Table 121. Johnson & Johnson Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 122. Johnson & Johnson Liposomes Product and Services
Table 123. Johnson & Johnson Liposomes SWOT Analysis
Table 124. Johnson & Johnson Recent Developments
Table 125. Gilead Sciences Company Information
Table 126. Gilead Sciences Description and Overview
Table 127. Gilead Sciences Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 128. Gilead Sciences Liposomes Product and Services
Table 129. Gilead Sciences Liposomes SWOT Analysis
Table 130. Gilead Sciences Recent Developments
Table 131. Pacira Company Information
Table 132. Pacira Description and Overview
Table 133. Pacira Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 134. Pacira Liposomes Product and Services
Table 135. Pacira Liposomes SWOT Analysis
Table 136. Pacira Recent Developments
Table 137. Sun Pharmaceutical Company Information
Table 138. Sun Pharmaceutical Description and Overview
Table 139. Sun Pharmaceutical Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 140. Sun Pharmaceutical Liposomes Product and Services
Table 141. Sun Pharmaceutical Liposomes SWOT Analysis
Table 142. Sun Pharmaceutical Recent Developments
Table 143. Luye Pharma Company Information
Table 144. Luye Pharma Description and Overview
Table 145. Luye Pharma Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 146. Luye Pharma Liposomes Product and Services
Table 147. Luye Pharma Liposomes SWOT Analysis
Table 148. Luye Pharma Recent Developments
Table 149. Sigma-Tau Group Company Information
Table 150. Sigma-Tau Group Description and Overview
Table 151. Sigma-Tau Group Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 152. Sigma-Tau Group Liposomes Product and Services
Table 153. Sigma-Tau Group Liposomes SWOT Analysis
Table 154. Sigma-Tau Group Recent Developments
Table 155. Fudan-Zhangjiang Company Information
Table 156. Fudan-Zhangjiang Description and Overview
Table 157. Fudan-Zhangjiang Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 158. Fudan-Zhangjiang Liposomes Product and Services
Table 159. Fudan-Zhangjiang Liposomes SWOT Analysis
Table 160. Fudan-Zhangjiang Recent Developments
Table 161. Teva Pharmaceutical Company Information
Table 162. Teva Pharmaceutical Description and Overview
Table 163. Teva Pharmaceutical Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 164. Teva Pharmaceutical Liposomes Product and Services
Table 165. Teva Pharmaceutical Liposomes SWOT Analysis
Table 166. Teva Pharmaceutical Recent Developments
Table 167. CSPC Company Information
Table 168. CSPC Description and Overview
Table 169. CSPC Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 170. CSPC Liposomes Product and Services
Table 171. CSPC Liposomes SWOT Analysis
Table 172. CSPC Recent Developments
Table 173. Novartis Company Information
Table 174. Novartis Description and Overview
Table 175. Novartis Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 176. Novartis Liposomes Product and Services
Table 177. Novartis Liposomes SWOT Analysis
Table 178. Novartis Recent Developments
Table 179. Kingond Pharm Company Information
Table 180. Kingond Pharm Description and Overview
Table 181. Kingond Pharm Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 182. Kingond Pharm Liposomes Product and Services
Table 183. Kingond Pharm Recent Developments
Table 184. Spectrum Pharmaceuticals Company Information
Table 185. Spectrum Pharmaceuticals Description and Overview
Table 186. Spectrum Pharmaceuticals Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 187. Spectrum Pharmaceuticals Liposomes Product and Services
Table 188. Spectrum Pharmaceuticals Recent Developments
Table 189. Shanghai New Asia Company Information
Table 190. Shanghai New Asia Description and Overview
Table 191. Shanghai New Asia Liposomes Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 192. Shanghai New Asia Liposomes Product and Services
Table 193. Shanghai New Asia Recent Developments
Table 194. Key Raw Materials Lists
Table 195. Raw Materials Key Suppliers Lists
Table 196. Liposomes Distributors List
Table 197. Liposomes Customers List
Table 198. Liposomes Market Trends
Table 199. Liposomes Market Drivers
Table 200. Liposomes Market Challenges
Table 201. Liposomes Market Restraints
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomes Product Picture
Figure 2. Global Liposomes Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Liposomes Market Share by Type in 2024 & 2034
Figure 4. Liposomal Doxorubicin Product Picture
Figure 5. Liposomal Amphoteracin B Product Picture
Figure 6. Liposomal Paclitaxel Product Picture
Figure 7. Others Product Picture
Figure 8. Global Liposomes Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global Liposomes Market Share by Application in 2024 & 2034
Figure 10. Fungal Infection Therapy
Figure 11. Cancer & Tumor Therapy
Figure 12. Others
Figure 13. Liposomes Report Years Considered
Figure 14. Global Liposomes Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Liposomes Revenue 2018-2034 (US$ Million)
Figure 16. Global Liposomes Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 17. Global Liposomes Sales Quantity 2018-2034 (K Units)
Figure 18. Global Liposomes Sales Quantity Market Share by Region (2018-2023)
Figure 19. Global Liposomes Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Liposomes Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. North America Liposomes Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Liposomes Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. Europe Liposomes Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Liposomes Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. China Liposomes Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Liposomes Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. APAC Liposomes Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Liposomes Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Liposomes Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Liposomes Sales Quantity in 2024
Figure 31. The Top 10 and Top 5 Players Market Share by Liposomes Revenue in 2024
Figure 32. Liposomes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 33. Global Liposomes Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Liposomes Revenue Market Share by Type (2018-2034)
Figure 35. Global Liposomes Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Liposomes Revenue Market Share by Application (2018-2034)
Figure 37. North America Liposomes Revenue Market Share by Company in 2024
Figure 38. North America Liposomes Sales Quantity Market Share by Company in 2024
Figure 39. North America Liposomes Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Liposomes Revenue Market Share by Type (2018-2034)
Figure 41. North America Liposomes Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Liposomes Revenue Market Share by Application (2018-2034)
Figure 43. North America Liposomes Revenue Share by Country (2018-2034)
Figure 44. North America Liposomes Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Liposomes Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Liposomes Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Liposomes Sales Quantity Market Share by Company in 2024
Figure 48. Europe Liposomes Revenue Market Share by Company in 2024
Figure 49. Europe Liposomes Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Liposomes Revenue Market Share by Type (2018-2034)
Figure 51. Europe Liposomes Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Liposomes Revenue Market Share by Application (2018-2034)
Figure 53. Europe Liposomes Revenue Share by Country (2018-2034)
Figure 54. Europe Liposomes Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Liposomes Revenue (2018-2034) & (US$ Million)
Figure 56. France Liposomes Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Liposomes Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Liposomes Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Liposomes Revenue (2018-2034) & (US$ Million)
Figure 60. China Liposomes Sales Quantity Market Share by Company in 2024
Figure 61. China Liposomes Revenue Market Share by Company in 2024
Figure 62. China Liposomes Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Liposomes Revenue Market Share by Type (2018-2034)
Figure 64. China Liposomes Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Liposomes Revenue Market Share by Application (2018-2034)
Figure 66. APAC Liposomes Sales Quantity Market Share by Company in 2024
Figure 67. APAC Liposomes Revenue Market Share by Company in 2024
Figure 68. APAC Liposomes Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Liposomes Revenue Market Share by Type (2018-2034)
Figure 70. APAC Liposomes Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Liposomes Revenue Market Share by Application (2018-2034)
Figure 72. APAC Liposomes Revenue Share by Region (2018-2034)
Figure 73. APAC Liposomes Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Liposomes Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Liposomes Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Liposomes Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Liposomes Revenue (2018-2034) & (US$ Million)
Figure 78. India Liposomes Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Liposomes Sales Quantity Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Liposomes Revenue Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Liposomes Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Liposomes Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Liposomes Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Liposomes Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Liposomes Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Liposomes Revenue Share by Country (2018-2034)
Figure 87. Brazil Liposomes Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Liposomes Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Liposomes Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Liposomes Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Liposomes Revenue (2018-2034) & (US$ Million)
Figure 92. Liposomes Value Chain
Figure 93. Liposomes Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed